Nascent Biotech, Inc.
NBIO · OTC
9/30/2024 | 6/30/2024 | 3/31/2024 | 12/31/2023 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | – | -$377 | -$513 | -$205 |
| Dep. & Amort. | – | $0 | -$3 | $0 |
| Deferred Tax | – | $0 | $0 | $0 |
| Stock-Based Comp. | – | $56 | $126 | $77 |
| Change in WC | – | -$3 | $38 | -$57 |
| Other Non-Cash | – | $0 | $0 | -$145 |
| Operating Cash Flow | – | -$325 | -$352 | -$330 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | – | $0 | $0 | $0 |
| Net Acquisitions | – | $0 | $0 | $0 |
| Inv. Purchases | – | $0 | $0 | $0 |
| Inv. Sales/Matur. | – | $0 | $0 | $0 |
| Other Inv. Act. | – | $0 | $0 | $0 |
| Investing Cash Flow | – | $0 | $0 | $0 |
| Financing Activities | – | – | – | – |
| Debt Repay. | – | $0 | $0 | -$75 |
| Stock Issued | – | $64 | $100 | $25 |
| Stock Repurch. | – | $0 | $0 | $0 |
| Dividends Paid | – | $0 | $0 | $0 |
| Other Fin. Act. | – | $0 | $0 | $0 |
| Financing Cash Flow | – | $0 | $100 | -$50 |
| Forex Effect | – | $0 | $0 | $0 |
| Net Chg. in Cash | – | -$325 | -$252 | -$380 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | – | $372 | $624 | $1,004 |
| End Cash | – | $47 | $372 | $624 |
| Free Cash Flow | – | -$325 | -$352 | -$330 |